Author
Listed:
- Anna Tafuri
(Amgen Institute
Ontario Cancer Institute, University of Toronto)
- Arda Shahinian
(Amgen Institute
Ontario Cancer Institute, University of Toronto)
- Friedhelm Bladt
(Mount Sinai Hospital, Samuel Lunenfeld Research Institute)
- Steve K. Yoshinaga
(Amgen)
- Manel Jordana
(Faculty of Health Science, McMaster University)
- Andrew Wakeham
(Amgen Institute
Ontario Cancer Institute, University of Toronto)
- Louis-Martin Boucher
(Amgen Institute
Ontario Cancer Institute, University of Toronto)
- Denis Bouchard
(Amgen Institute
Ontario Cancer Institute, University of Toronto)
- Vera S. F. Chan
(Ontario Cancer Institute, University of Toronto)
- Gordon Duncan
(Amgen Institute
Ontario Cancer Institute, University of Toronto)
- Bernhard Odermatt
(University Hospital Zurich)
- Alexandra Ho
(Amgen Institute
Ontario Cancer Institute, University of Toronto)
- Annick Itie
(Amgen Institute
Ontario Cancer Institute, University of Toronto)
- Tom Horan
(Amgen)
- John S. Whoriskey
(Amgen)
- Tony Pawson
(Mount Sinai Hospital, Samuel Lunenfeld Research Institute)
- Josef M. Penninger
(Amgen Institute
Ontario Cancer Institute, University of Toronto)
- Pamela S. Ohashi
(Ontario Cancer Institute, University of Toronto)
- Tak W. Mak
(Amgen Institute
Ontario Cancer Institute, University of Toronto)
Abstract
The outcome of T-cell responses after T-cell encounter with specific antigens is modulated by co-stimulatory signals, which are required for both lymphocyte activation and development of adaptive immunity1,2,3. ICOS4,5, an inducible co-stimulator with homology to CD28, is expressed on activated, but not resting T cells, and shows T-cell co-stimulatory function in vitro. ICOS binds specifically to its counter-receptor B7RP-1 (refs 5,6,7), but not to B7-1 or B7-2. Here we provide in vivo genetic evidence that ICOS delivers a co-stimulatory signal that is essential both for efficient interaction between T and B cells and for normal antibody responses to T-cell-dependent antigens. To determine the physiological function of ICOS, we generated and characterized gene-targeted ICOS-deficient mice. In vivo, a lack of ICOS results in severely deficient T-cell-dependent B-cell responses. Germinal centre formation is impaired and immunoglobulin class switching, including production of allergy-mediating IgE, is defective. ICOS-deficient T cells primed in in vivo and restimulated in vitro with specific antigen produce only low levels of interleukin-4, but remain fully competent to produce interferon-γ.
Suggested Citation
Anna Tafuri & Arda Shahinian & Friedhelm Bladt & Steve K. Yoshinaga & Manel Jordana & Andrew Wakeham & Louis-Martin Boucher & Denis Bouchard & Vera S. F. Chan & Gordon Duncan & Bernhard Odermatt & Ale, 2001.
"ICOS is essential for effective T-helper-cell responses,"
Nature, Nature, vol. 409(6816), pages 105-109, January.
Handle:
RePEc:nat:nature:v:409:y:2001:i:6816:d:10.1038_35051113
DOI: 10.1038/35051113
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:409:y:2001:i:6816:d:10.1038_35051113. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.